

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cellular extravasation (GO:0045123) | 8.46164880 |
| 2 | leukocyte aggregation (GO:0070486) | 8.30154412 |
| 3 | leukocyte migration involved in inflammatory response (GO:0002523) | 7.31532074 |
| 4 | neutrophil mediated immunity (GO:0002446) | 7.19570412 |
| 5 | defense response to fungus (GO:0050832) | 7.00910894 |
| 6 | neutrophil activation involved in immune response (GO:0002283) | 6.84770489 |
| 7 | positive regulation of mast cell activation (GO:0033005) | 6.23784561 |
| 8 | response to peptidoglycan (GO:0032494) | 6.23426702 |
| 9 | neutrophil activation (GO:0042119) | 6.12096940 |
| 10 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.82890576 |
| 11 | neutrophil chemotaxis (GO:0030593) | 5.81287190 |
| 12 | respiratory burst (GO:0045730) | 5.76335201 |
| 13 | neutrophil migration (GO:1990266) | 5.65913070 |
| 14 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 5.61891689 |
| 15 | production of molecular mediator involved in inflammatory response (GO:0002532) | 5.61530128 |
| 16 | granulocyte activation (GO:0036230) | 5.59797115 |
| 17 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 5.56870860 |
| 18 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 5.56870860 |
| 19 | detection of other organism (GO:0098543) | 5.55622918 |
| 20 | detection of bacterium (GO:0016045) | 5.53912136 |
| 21 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 5.53415779 |
| 22 | response to host immune response (GO:0052572) | 5.53415779 |
| 23 | myeloid leukocyte mediated immunity (GO:0002444) | 5.49990875 |
| 24 | response to fungus (GO:0009620) | 5.43298201 |
| 25 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 5.18689794 |
| 26 | response to host (GO:0075136) | 5.18689794 |
| 27 | response to host defenses (GO:0052200) | 5.18689794 |
| 28 | regulation of mononuclear cell migration (GO:0071675) | 5.16354683 |
| 29 | granulocyte chemotaxis (GO:0071621) | 4.90484621 |
| 30 | regulation of mast cell activation (GO:0033003) | 4.88714487 |
| 31 | granulocyte migration (GO:0097530) | 4.87877978 |
| 32 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.75324500 |
| 33 | glycosphingolipid catabolic process (GO:0046479) | 4.74512264 |
| 34 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 4.73511292 |
| 35 | negative regulation of cell killing (GO:0031342) | 4.65394215 |
| 36 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.65394215 |
| 37 | diterpenoid biosynthetic process (GO:0016102) | 4.63685250 |
| 38 | sequestering of metal ion (GO:0051238) | 4.61268117 |
| 39 | regulation of leukocyte degranulation (GO:0043300) | 4.56966761 |
| 40 | oligosaccharide catabolic process (GO:0009313) | 4.47156756 |
| 41 | cellular response to thyroid hormone stimulus (GO:0097067) | 4.44017684 |
| 42 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.31965172 |
| 43 | glycolipid catabolic process (GO:0019377) | 4.25723240 |
| 44 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 4.24006332 |
| 45 | positive regulation of mast cell degranulation (GO:0043306) | 4.24006332 |
| 46 | regulation of mast cell degranulation (GO:0043304) | 4.23585906 |
| 47 | negative regulation of phagocytosis (GO:0050765) | 4.22831797 |
| 48 | positive regulation by symbiont of host defense response (GO:0052509) | 4.21291674 |
| 49 | modulation by symbiont of host defense response (GO:0052031) | 4.21291674 |
| 50 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.21291674 |
| 51 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.21291674 |
| 52 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.21291674 |
| 53 | modulation by symbiont of host immune response (GO:0052553) | 4.21291674 |
| 54 | progesterone metabolic process (GO:0042448) | 4.20538265 |
| 55 | regulation of regulated secretory pathway (GO:1903305) | 4.19601632 |
| 56 | killing of cells of other organism (GO:0031640) | 4.11703995 |
| 57 | disruption of cells of other organism (GO:0044364) | 4.11703995 |
| 58 | amino sugar catabolic process (GO:0046348) | 4.04426112 |
| 59 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 4.04344059 |
| 60 | monocyte chemotaxis (GO:0002548) | 4.01644617 |
| 61 | regulation of podosome assembly (GO:0071801) | 4.00739059 |
| 62 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.99160556 |
| 63 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.93838868 |
| 64 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.93430855 |
| 65 | pentose-phosphate shunt (GO:0006098) | 3.88598582 |
| 66 | cellular response to zinc ion (GO:0071294) | 3.83379642 |
| 67 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.82227027 |
| 68 | ceramide catabolic process (GO:0046514) | 3.79121164 |
| 69 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.77644608 |
| 70 | positive regulation of heat generation (GO:0031652) | 3.76807386 |
| 71 | phagosome maturation (GO:0090382) | 3.75435208 |
| 72 | positive regulation of osteoblast proliferation (GO:0033690) | 3.73939289 |
| 73 | negative regulation of mast cell activation (GO:0033004) | 3.72584162 |
| 74 | regulation of vitamin metabolic process (GO:0030656) | 3.71548825 |
| 75 | regulation of macrophage chemotaxis (GO:0010758) | 3.67636007 |
| 76 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 3.65126508 |
| 77 | NIK/NF-kappaB signaling (GO:0038061) | 3.64653248 |
| 78 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.64289669 |
| 79 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.62478041 |
| 80 | positive regulation of lamellipodium assembly (GO:0010592) | 3.62173800 |
| 81 | myeloid dendritic cell differentiation (GO:0043011) | 3.60585617 |
| 82 | leukocyte cell-cell adhesion (GO:0007159) | 3.52973166 |
| 83 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.52922320 |
| 84 | regulation of fever generation (GO:0031620) | 3.52823092 |
| 85 | immunoglobulin mediated immune response (GO:0016064) | 3.51474940 |
| 86 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.51283544 |
| 87 | myeloid leukocyte migration (GO:0097529) | 3.50920813 |
| 88 | eosinophil chemotaxis (GO:0048245) | 3.49067503 |
| 89 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.48507753 |
| 90 | membrane lipid catabolic process (GO:0046466) | 3.47901350 |
| 91 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.47765360 |
| 92 | NADPH regeneration (GO:0006740) | 3.46822243 |
| 93 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.46716443 |
| 94 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.46209415 |
| 95 | dendritic cell migration (GO:0036336) | 3.45223940 |
| 96 | dendritic cell chemotaxis (GO:0002407) | 3.44835360 |
| 97 | adaptation of signaling pathway (GO:0023058) | 3.44287621 |
| 98 | response to thyroid hormone (GO:0097066) | 3.44244877 |
| 99 | superoxide anion generation (GO:0042554) | 3.43392290 |
| 100 | T-helper 1 type immune response (GO:0042088) | 3.41191286 |
| 101 | regulation of chemokine biosynthetic process (GO:0045073) | 3.39767272 |
| 102 | * endodermal cell differentiation (GO:0035987) | 3.35118489 |
| 103 | cellular response to cadmium ion (GO:0071276) | 3.33901500 |
| 104 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.32641282 |
| 105 | detection of external biotic stimulus (GO:0098581) | 3.31597612 |
| 106 | sphingolipid catabolic process (GO:0030149) | 3.28738823 |
| 107 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.27854868 |
| 108 | regulation of natural killer cell differentiation (GO:0032823) | 3.27369829 |
| 109 | defense response to Gram-positive bacterium (GO:0050830) | 3.26660460 |
| 110 | chronic inflammatory response (GO:0002544) | 3.24971120 |
| 111 | positive regulation of leukocyte degranulation (GO:0043302) | 3.22814908 |
| 112 | regulation of cholesterol storage (GO:0010885) | 3.22570758 |
| 113 | myeloid dendritic cell activation (GO:0001773) | 3.20763410 |
| 114 | leukocyte chemotaxis (GO:0030595) | 3.18708942 |
| 115 | N-acetylneuraminate metabolic process (GO:0006054) | 3.16511567 |
| 116 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.14545717 |
| 117 | mucosal immune response (GO:0002385) | 3.13608233 |
| 118 | macrophage activation involved in immune response (GO:0002281) | 3.12614738 |
| 119 | eosinophil migration (GO:0072677) | 3.11728357 |
| 120 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.11608392 |
| 121 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.11405356 |
| 122 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.10831725 |
| 123 | germinal center formation (GO:0002467) | 3.10357834 |
| 124 | leukocyte degranulation (GO:0043299) | 3.09446749 |
| 125 | * macrophage differentiation (GO:0030225) | 3.08505108 |
| 126 | terpenoid biosynthetic process (GO:0016114) | 3.07521870 |
| 127 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.07296372 |
| 128 | leukotriene metabolic process (GO:0006691) | 3.04560780 |
| 129 | reactive oxygen species biosynthetic process (GO:1903409) | 3.03921281 |
| 130 | positive regulation of vesicle fusion (GO:0031340) | 3.03832098 |
| 131 | negative regulation of interleukin-12 production (GO:0032695) | 3.02353298 |
| 132 | leukotriene biosynthetic process (GO:0019370) | 3.02027846 |
| 133 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.01672488 |
| 134 | natural killer cell activation involved in immune response (GO:0002323) | 3.01635757 |
| 135 | cellular response to lipopolysaccharide (GO:0071222) | 3.01551777 |
| 136 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.01164697 |
| 137 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.00344855 |
| 138 | regulation of B cell differentiation (GO:0045577) | 2.99591841 |
| 139 | positive regulation of regulated secretory pathway (GO:1903307) | 2.98563367 |
| 140 | detection of molecule of bacterial origin (GO:0032490) | 2.98431051 |
| 141 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.98041644 |
| 142 | decidualization (GO:0046697) | 2.96774818 |
| 143 | response to protozoan (GO:0001562) | 2.96510419 |
| 144 | organ or tissue specific immune response (GO:0002251) | 2.95542960 |
| 145 | cellular response to molecule of bacterial origin (GO:0071219) | 2.92725278 |
| 146 | positive regulation of lamellipodium organization (GO:1902745) | 2.92692024 |
| 147 | regulation of interferon-alpha production (GO:0032647) | 2.92649497 |
| 148 | positive regulation of antigen processing and presentation (GO:0002579) | 2.92586137 |
| 149 | virion attachment to host cell (GO:0019062) | 2.90244871 |
| 150 | adhesion of symbiont to host cell (GO:0044650) | 2.90244871 |
| 151 | response to muramyl dipeptide (GO:0032495) | 2.90062883 |
| 152 | actin nucleation (GO:0045010) | 2.89900571 |
| 153 | macrophage activation (GO:0042116) | 2.89396633 |
| 154 | dendritic cell differentiation (GO:0097028) | 2.88409563 |
| 155 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.87022227 |
| 156 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.85366245 |
| 157 | leukocyte mediated cytotoxicity (GO:0001909) | 2.85230941 |
| 158 | defense response to protozoan (GO:0042832) | 2.83559609 |
| 159 | barbed-end actin filament capping (GO:0051016) | 2.82835414 |
| 160 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.82811688 |
| 161 | myeloid cell activation involved in immune response (GO:0002275) | 2.82354695 |
| 162 | innate immune response in mucosa (GO:0002227) | 2.81867894 |
| 163 | regulation of heat generation (GO:0031650) | 2.80486605 |
| 164 | positive regulation of interleukin-6 production (GO:0032755) | 2.77557632 |
| 165 | regulation of antigen processing and presentation (GO:0002577) | 2.76952363 |
| 166 | cellular response to arsenic-containing substance (GO:0071243) | 2.76026650 |
| 167 | regulation of chronic inflammatory response (GO:0002676) | 2.74768248 |
| 168 | negative regulation of lipid storage (GO:0010888) | 2.73755429 |
| 169 | regulation of interleukin-12 production (GO:0032655) | 2.73506653 |
| 170 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.72553062 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.27257943 |
| 2 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 4.77619545 |
| 3 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 4.07227383 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.73978393 |
| 5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.57296138 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.49291806 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.44683679 |
| 8 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.40604845 |
| 9 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 3.24578837 |
| 10 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.24232988 |
| 11 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.22018616 |
| 12 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.80077490 |
| 13 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.77585771 |
| 14 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.72241622 |
| 15 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.58216700 |
| 16 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.50773301 |
| 17 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.30962808 |
| 18 | SPI1_23127762_ChIP-Seq_K562_Human | 2.24404771 |
| 19 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.21041405 |
| 20 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.11209918 |
| 21 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.07614534 |
| 22 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.01417291 |
| 23 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.92168910 |
| 24 | MAF_26560356_Chip-Seq_TH1_Human | 1.91455874 |
| 25 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.91359904 |
| 26 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.87762559 |
| 27 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.84899490 |
| 28 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.78739493 |
| 29 | * MYB_26560356_Chip-Seq_TH2_Human | 1.78374773 |
| 30 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.77096343 |
| 31 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.75793718 |
| 32 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.75706958 |
| 33 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.75156743 |
| 34 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.72286448 |
| 35 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.68291249 |
| 36 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.68187355 |
| 37 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.64334187 |
| 38 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63681325 |
| 39 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.62295734 |
| 40 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.62085110 |
| 41 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.61923891 |
| 42 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.59345155 |
| 43 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.58678596 |
| 44 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.54519656 |
| 45 | MYB_26560356_Chip-Seq_TH1_Human | 1.51512100 |
| 46 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.48922056 |
| 47 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.48600139 |
| 48 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.45635699 |
| 49 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.43706610 |
| 50 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.43228401 |
| 51 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.43219333 |
| 52 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.40826959 |
| 53 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.39924789 |
| 54 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.39921418 |
| 55 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.38437781 |
| 56 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.36836039 |
| 57 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.35006966 |
| 58 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.34555444 |
| 59 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.33300022 |
| 60 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.30888586 |
| 61 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.28295952 |
| 62 | GATA2_19941826_ChIP-Seq_K562_Human | 1.27676531 |
| 63 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23630111 |
| 64 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.22454876 |
| 65 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.22325385 |
| 66 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.20905347 |
| 67 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.20748856 |
| 68 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.20572731 |
| 69 | GATA1_19941826_ChIP-Seq_K562_Human | 1.20455095 |
| 70 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.20315268 |
| 71 | GATA1_22025678_ChIP-Seq_K562_Human | 1.18789272 |
| 72 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.17751306 |
| 73 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.17645878 |
| 74 | GATA3_26560356_Chip-Seq_TH2_Human | 1.16319668 |
| 75 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15398416 |
| 76 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.14726910 |
| 77 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.14572638 |
| 78 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.13117884 |
| 79 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.12802554 |
| 80 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.11979412 |
| 81 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09601611 |
| 82 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.09219999 |
| 83 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.07492579 |
| 84 | MAF_26560356_Chip-Seq_TH2_Human | 1.06888349 |
| 85 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.05272465 |
| 86 | MYC_22102868_ChIP-Seq_BL_Human | 1.03408514 |
| 87 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.03010160 |
| 88 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02955319 |
| 89 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.02943145 |
| 90 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.02593578 |
| 91 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02393895 |
| 92 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.02122987 |
| 93 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.01880337 |
| 94 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.01605637 |
| 95 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01521539 |
| 96 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.00062795 |
| 97 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98378284 |
| 98 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.97624376 |
| 99 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.96972935 |
| 100 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.96677881 |
| 101 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96647709 |
| 102 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96398516 |
| 103 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.95772789 |
| 104 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.95365114 |
| 105 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95319437 |
| 106 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.95142672 |
| 107 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.93730195 |
| 108 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.93127879 |
| 109 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.93052592 |
| 110 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92619317 |
| 111 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.91905569 |
| 112 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.91832711 |
| 113 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.90041591 |
| 114 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.89938477 |
| 115 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89320788 |
| 116 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.89075382 |
| 117 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.88865297 |
| 118 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.86845612 |
| 119 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.86653892 |
| 120 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.85588007 |
| 121 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.83651592 |
| 122 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.83371710 |
| 123 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.82533246 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 5.83824953 |
| 2 | * MP0003436_decreased_susceptibility_to | 4.66289554 |
| 3 | * MP0002419_abnormal_innate_immunity | 3.80652368 |
| 4 | MP0009840_abnormal_foam_cell | 3.71472273 |
| 5 | MP0003724_increased_susceptibility_to | 3.29506333 |
| 6 | * MP0009785_altered_susceptibility_to | 3.22551110 |
| 7 | MP0003183_abnormal_peptide_metabolism | 3.17788915 |
| 8 | MP0002139_abnormal_hepatobiliary_system | 3.05568318 |
| 9 | * MP0001533_abnormal_skeleton_physiology | 2.83265776 |
| 10 | * MP0005025_abnormal_response_to | 2.76103510 |
| 11 | MP0003300_gastrointestinal_ulcer | 2.50860296 |
| 12 | MP0002277_abnormal_respiratory_mucosa | 2.48230458 |
| 13 | MP0000685_abnormal_immune_system | 2.43411269 |
| 14 | MP0003828_pulmonary_edema | 2.42780178 |
| 15 | MP0001835_abnormal_antigen_presentation | 2.32145018 |
| 16 | * MP0005000_abnormal_immune_tolerance | 2.26543932 |
| 17 | * MP0009278_abnormal_bone_marrow | 2.21853040 |
| 18 | MP0005464_abnormal_platelet_physiology | 2.16895111 |
| 19 | * MP0001819_abnormal_immune_cell | 2.15107044 |
| 20 | * MP0002452_abnormal_antigen_presenting | 2.13597862 |
| 21 | * MP0002420_abnormal_adaptive_immunity | 2.13206794 |
| 22 | MP0004510_myositis | 2.11341582 |
| 23 | MP0002396_abnormal_hematopoietic_system | 2.09566138 |
| 24 | MP0001851_eye_inflammation | 2.04855247 |
| 25 | * MP0001845_abnormal_inflammatory_respons | 1.99509379 |
| 26 | * MP0002405_respiratory_system_inflammati | 1.98239215 |
| 27 | * MP0002148_abnormal_hypersensitivity_rea | 1.97529787 |
| 28 | * MP0000343_altered_response_to | 1.96878773 |
| 29 | MP0005451_abnormal_body_composition | 1.96688247 |
| 30 | MP0000465_gastrointestinal_hemorrhage | 1.93047450 |
| 31 | MP0005076_abnormal_cell_differentiation | 1.91421031 |
| 32 | MP0003191_abnormal_cellular_cholesterol | 1.88603494 |
| 33 | * MP0001800_abnormal_humoral_immune | 1.87329101 |
| 34 | MP0005387_immune_system_phenotype | 1.86607971 |
| 35 | MP0001790_abnormal_immune_system | 1.86607971 |
| 36 | MP0003566_abnormal_cell_adhesion | 1.85923049 |
| 37 | * MP0002723_abnormal_immune_serum | 1.83903954 |
| 38 | * MP0000858_altered_metastatic_potential | 1.73628010 |
| 39 | MP0002254_reproductive_system_inflammat | 1.73299225 |
| 40 | MP0005310_abnormal_salivary_gland | 1.72011926 |
| 41 | MP0003690_abnormal_glial_cell | 1.68024123 |
| 42 | MP0001958_emphysema | 1.67073663 |
| 43 | * MP0009764_decreased_sensitivity_to | 1.65374298 |
| 44 | * MP0003075_altered_response_to | 1.63988267 |
| 45 | MP0008260_abnormal_autophagy | 1.60453049 |
| 46 | MP0004947_skin_inflammation | 1.59639740 |
| 47 | * MP0005023_abnormal_wound_healing | 1.58668816 |
| 48 | MP0003195_calcinosis | 1.56070253 |
| 49 | * MP0005390_skeleton_phenotype | 1.54611639 |
| 50 | * MP0000716_abnormal_immune_system | 1.44425478 |
| 51 | MP0008004_abnormal_stomach_pH | 1.40957741 |
| 52 | MP0005671_abnormal_response_to | 1.39976209 |
| 53 | MP0005058_abnormal_lysosome_morphology | 1.38003129 |
| 54 | * MP0003448_altered_tumor_morphology | 1.36983699 |
| 55 | MP0003705_abnormal_hypodermis_morpholog | 1.34742274 |
| 56 | * MP0002398_abnormal_bone_marrow | 1.33267694 |
| 57 | * MP0008469_abnormal_protein_level | 1.30974191 |
| 58 | * MP0004883_abnormal_blood_vessel | 1.23489752 |
| 59 | MP0002133_abnormal_respiratory_system | 1.20721577 |
| 60 | MP0005388_respiratory_system_phenotype | 1.20721577 |
| 61 | MP0003806_abnormal_nucleotide_metabolis | 1.19899562 |
| 62 | * MP0002429_abnormal_blood_cell | 1.18384528 |
| 63 | * MP0005164_abnormal_response_to | 1.16588306 |
| 64 | MP0002132_abnormal_respiratory_system | 1.16242766 |
| 65 | MP0000689_abnormal_spleen_morphology | 1.15290318 |
| 66 | * MP0005166_decreased_susceptibility_to | 1.14747251 |
| 67 | MP0006082_CNS_inflammation | 1.13887792 |
| 68 | * MP0005397_hematopoietic_system_phenotyp | 1.13735207 |
| 69 | * MP0001545_abnormal_hematopoietic_system | 1.13735207 |
| 70 | MP0003123_paternal_imprinting | 1.13392904 |
| 71 | MP0008438_abnormal_cutaneous_collagen | 1.09917097 |
| 72 | * MP0004808_abnormal_hematopoietic_stem | 1.09310553 |
| 73 | MP0006054_spinal_hemorrhage | 1.08979310 |
| 74 | MP0003950_abnormal_plasma_membrane | 1.08330897 |
| 75 | * MP0010155_abnormal_intestine_physiology | 1.08321431 |
| 76 | MP0000604_amyloidosis | 1.07366548 |
| 77 | MP0002722_abnormal_immune_system | 1.04792323 |
| 78 | * MP0002933_joint_inflammation | 1.03212819 |
| 79 | MP0003656_abnormal_erythrocyte_physiolo | 1.01142774 |
| 80 | MP0005365_abnormal_bile_salt | 0.98863979 |
| 81 | MP0001542_abnormal_bone_strength | 0.98782399 |
| 82 | MP0002998_abnormal_bone_remodeling | 0.98575317 |
| 83 | MP0010234_abnormal_vibrissa_follicle | 0.98105153 |
| 84 | MP0005165_increased_susceptibility_to | 0.97795954 |
| 85 | MP0002282_abnormal_trachea_morphology | 0.97785089 |
| 86 | MP0002060_abnormal_skin_morphology | 0.93771816 |
| 87 | MP0002332_abnormal_exercise_endurance | 0.91961159 |
| 88 | MP0000569_abnormal_digit_pigmentation | 0.90801565 |
| 89 | MP0003172_abnormal_lysosome_physiology | 0.88856446 |
| 90 | MP0001663_abnormal_digestive_system | 0.87544936 |
| 91 | MP0010307_abnormal_tumor_latency | 0.86034968 |
| 92 | * MP0003795_abnormal_bone_structure | 0.84696656 |
| 93 | MP0005647_abnormal_sex_gland | 0.84634042 |
| 94 | MP0003091_abnormal_cell_migration | 0.83329296 |
| 95 | * MP0005167_abnormal_blood-brain_barrier | 0.83186820 |
| 96 | MP0002877_abnormal_melanocyte_morpholog | 0.80849713 |
| 97 | MP0005257_abnormal_intraocular_pressure | 0.75873272 |
| 98 | * MP0000920_abnormal_myelination | 0.74895980 |
| 99 | * MP0003634_abnormal_glial_cell | 0.74563931 |
| 100 | MP0002090_abnormal_vision | 0.74185713 |
| 101 | MP0003329_amyloid_beta_deposits | 0.73614708 |
| 102 | MP0001849_ear_inflammation | 0.72745292 |
| 103 | MP0000371_diluted_coat_color | 0.72670788 |
| 104 | MP0000516_abnormal_urinary_system | 0.72178720 |
| 105 | MP0005367_renal/urinary_system_phenotyp | 0.72178720 |
| 106 | MP0009931_abnormal_skin_appearance | 0.70369722 |
| 107 | MP0002166_altered_tumor_susceptibility | 0.70288249 |
| 108 | * MP0009763_increased_sensitivity_to | 0.69242679 |
| 109 | MP0002928_abnormal_bile_duct | 0.69216974 |
| 110 | MP0001873_stomach_inflammation | 0.69129181 |
| 111 | MP0005319_abnormal_enzyme/_coenzyme | 0.68347692 |
| 112 | MP0002138_abnormal_hepatobiliary_system | 0.66140771 |
| 113 | MP0010352_gastrointestinal_tract_polyps | 0.65907215 |
| 114 | MP0002971_abnormal_brown_adipose | 0.65796536 |
| 115 | MP0009333_abnormal_splenocyte_physiolog | 0.65530236 |
| 116 | * MP0008874_decreased_physiological_sensi | 0.64184318 |
| 117 | * MP0001853_heart_inflammation | 0.63755492 |
| 118 | MP0003186_abnormal_redox_activity | 0.63655056 |
| 119 | MP0004381_abnormal_hair_follicle | 0.63650301 |
| 120 | MP0000703_abnormal_thymus_morphology | 0.63639601 |
| 121 | MP0002896_abnormal_bone_mineralization | 0.62398768 |
| 122 | MP0005174_abnormal_tail_pigmentation | 0.61836081 |
| 123 | * MP0003453_abnormal_keratinocyte_physiol | 0.61286545 |
| 124 | MP0005381_digestive/alimentary_phenotyp | 0.60625807 |
| 125 | * MP0000249_abnormal_blood_vessel | 0.59162518 |
| 126 | MP0000609_abnormal_liver_physiology | 0.58968491 |
| 127 | * MP0009765_abnormal_xenobiotic_induced | 0.58774256 |
| 128 | MP0005248_abnormal_Harderian_gland | 0.57740728 |
| 129 | * MP0005595_abnormal_vascular_smooth | 0.54109024 |
| 130 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.54045682 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 9.12412064 |
| 2 | Eczematoid dermatitis (HP:0000976) | 8.79510455 |
| 3 | Recurrent gram-negative bacterial infections (HP:0005420) | 8.32692711 |
| 4 | Abnormality of liposaccharide metabolism (HP:0010968) | 8.28936859 |
| 5 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 8.28936859 |
| 6 | Abnormality of glycolipid metabolism (HP:0010969) | 8.28936859 |
| 7 | Recurrent bacterial skin infections (HP:0005406) | 7.54276842 |
| 8 | Abnormality of macrophages (HP:0004311) | 6.16244914 |
| 9 | Chronic obstructive pulmonary disease (HP:0006510) | 5.63987056 |
| 10 | Obstructive lung disease (HP:0006536) | 5.63987056 |
| 11 | Stomatitis (HP:0010280) | 5.60778574 |
| 12 | Gingivitis (HP:0000230) | 5.39002158 |
| 13 | Mediastinal lymphadenopathy (HP:0100721) | 5.21252384 |
| 14 | Disinhibition (HP:0000734) | 5.05800685 |
| 15 | Urticaria (HP:0001025) | 4.79565326 |
| 16 | Loss of speech (HP:0002371) | 4.68536041 |
| 17 | Mutism (HP:0002300) | 4.60273727 |
| 18 | Recurrent skin infections (HP:0001581) | 4.43854405 |
| 19 | Spontaneous hematomas (HP:0007420) | 4.36442688 |
| 20 | Myositis (HP:0100614) | 4.24533026 |
| 21 | Cellulitis (HP:0100658) | 4.11135367 |
| 22 | Recurrent fungal infections (HP:0002841) | 4.05716029 |
| 23 | Neurofibrillary tangles (HP:0002185) | 3.94337769 |
| 24 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.87064969 |
| 25 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.87064969 |
| 26 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.87064969 |
| 27 | Nuclear cataract (HP:0100018) | 3.63964839 |
| 28 | Orchitis (HP:0100796) | 3.59989679 |
| 29 | Peritonitis (HP:0002586) | 3.57269187 |
| 30 | Hepatosplenomegaly (HP:0001433) | 3.55058359 |
| 31 | Thickened calvaria (HP:0002684) | 3.47745093 |
| 32 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.42946099 |
| 33 | Glomerulonephritis (HP:0000099) | 3.42459597 |
| 34 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 3.22644998 |
| 35 | Abnormal platelet volume (HP:0011876) | 3.15471874 |
| 36 | Meningitis (HP:0001287) | 3.10185722 |
| 37 | Apathy (HP:0000741) | 3.06480271 |
| 38 | Agnosia (HP:0010524) | 3.06461098 |
| 39 | Diminished motivation (HP:0000745) | 3.04014495 |
| 40 | Hematochezia (HP:0002573) | 2.96712741 |
| 41 | Upper motor neuron abnormality (HP:0002127) | 2.90842213 |
| 42 | Inappropriate behavior (HP:0000719) | 2.87762255 |
| 43 | Periodontitis (HP:0000704) | 2.84018389 |
| 44 | Cerebral inclusion bodies (HP:0100314) | 2.83730809 |
| 45 | Neuronal loss in central nervous system (HP:0002529) | 2.75323403 |
| 46 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.71644196 |
| 47 | Myocardial infarction (HP:0001658) | 2.71523674 |
| 48 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.71314764 |
| 49 | Abnormality of iron homeostasis (HP:0011031) | 2.61656883 |
| 50 | Gingival bleeding (HP:0000225) | 2.59515733 |
| 51 | Progressive neurologic deterioration (HP:0002344) | 2.59093293 |
| 52 | Vacuolated lymphocytes (HP:0001922) | 2.53220893 |
| 53 | Complement deficiency (HP:0004431) | 2.53115622 |
| 54 | Increased mean platelet volume (HP:0011877) | 2.52243612 |
| 55 | Interstitial pulmonary disease (HP:0006530) | 2.47886251 |
| 56 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.45659332 |
| 57 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.45632358 |
| 58 | Recurrent cutaneous fungal infections (HP:0011370) | 2.45632358 |
| 59 | Personality changes (HP:0000751) | 2.42718707 |
| 60 | Retinal atrophy (HP:0001105) | 2.41069523 |
| 61 | Pustule (HP:0200039) | 2.40457695 |
| 62 | Episodic fever (HP:0001954) | 2.34928816 |
| 63 | Dementia (HP:0000726) | 2.34254839 |
| 64 | Prolonged neonatal jaundice (HP:0006579) | 2.33370250 |
| 65 | Skin ulcer (HP:0200042) | 2.33361333 |
| 66 | Sepsis (HP:0100806) | 2.30356623 |
| 67 | Pathologic fracture (HP:0002756) | 2.29577683 |
| 68 | Prolonged bleeding time (HP:0003010) | 2.28210977 |
| 69 | Pulmonary embolism (HP:0002204) | 2.28141340 |
| 70 | Osteomyelitis (HP:0002754) | 2.27230767 |
| 71 | Systemic lupus erythematosus (HP:0002725) | 2.26655704 |
| 72 | Keratoconjunctivitis sicca (HP:0001097) | 2.26115871 |
| 73 | Inflammation of the large intestine (HP:0002037) | 2.22366793 |
| 74 | Increased cerebral lipofuscin (HP:0011813) | 2.20395934 |
| 75 | Optic neuritis (HP:0100653) | 2.19806733 |
| 76 | Retrobulbar optic neuritis (HP:0100654) | 2.19806733 |
| 77 | Malnutrition (HP:0004395) | 2.18363250 |
| 78 | Leukocytosis (HP:0001974) | 2.18002976 |
| 79 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.17908437 |
| 80 | Protrusio acetabuli (HP:0003179) | 2.17803219 |
| 81 | Bone pain (HP:0002653) | 2.17282004 |
| 82 | Epistaxis (HP:0000421) | 2.16988933 |
| 83 | Premature rupture of membranes (HP:0001788) | 2.16860731 |
| 84 | Hypermelanotic macule (HP:0001034) | 2.14444748 |
| 85 | Nausea (HP:0002018) | 2.13859600 |
| 86 | Pulmonary infiltrates (HP:0002113) | 2.11905358 |
| 87 | Vasculitis (HP:0002633) | 2.11665540 |
| 88 | Conjunctival telangiectasia (HP:0000524) | 2.11226689 |
| 89 | Gastrointestinal inflammation (HP:0004386) | 2.11067489 |
| 90 | * Metaphyseal irregularity (HP:0003025) | 2.10600308 |
| 91 | Asymmetric septal hypertrophy (HP:0001670) | 2.10293471 |
| 92 | Recurrent pneumonia (HP:0006532) | 2.09367468 |
| 93 | Increased serum ferritin (HP:0003281) | 2.08668947 |
| 94 | Absent frontal sinuses (HP:0002688) | 2.08189984 |
| 95 | Persistence of primary teeth (HP:0006335) | 2.07841033 |
| 96 | Amyloidosis (HP:0011034) | 2.06998824 |
| 97 | Increased IgE level (HP:0003212) | 2.06827612 |
| 98 | Spondylolisthesis (HP:0003302) | 2.06670195 |
| 99 | Basal ganglia calcification (HP:0002135) | 2.06656461 |
| 100 | Petechiae (HP:0000967) | 2.05858805 |
| 101 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.05840709 |
| 102 | Nonimmune hydrops fetalis (HP:0001790) | 2.05583539 |
| 103 | Hemoptysis (HP:0002105) | 2.05133274 |
| 104 | Abnormality of the peritoneum (HP:0002585) | 2.04233707 |
| 105 | Asymmetry of the thorax (HP:0001555) | 2.03754011 |
| 106 | Keratoconjunctivitis (HP:0001096) | 2.03719028 |
| 107 | Abnormality of the common coagulation pathway (HP:0010990) | 2.02808320 |
| 108 | Polyneuropathy (HP:0001271) | 2.02659440 |
| 109 | Thoracic kyphosis (HP:0002942) | 2.02469715 |
| 110 | Dysostosis multiplex (HP:0000943) | 2.02047504 |
| 111 | Supranuclear gaze palsy (HP:0000605) | 1.99808930 |
| 112 | Chest pain (HP:0100749) | 1.99793639 |
| 113 | Abnormality of complement system (HP:0005339) | 1.95845133 |
| 114 | Peripheral demyelination (HP:0011096) | 1.94776823 |
| 115 | Recurrent lower respiratory tract infections (HP:0002783) | 1.93856536 |
| 116 | Cheilitis (HP:0100825) | 1.93345627 |
| 117 | Papilledema (HP:0001085) | 1.92038818 |
| 118 | Elevated alkaline phosphatase (HP:0003155) | 1.92027033 |
| 119 | Osteolytic defects of the hand bones (HP:0009699) | 1.89753595 |
| 120 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.89753595 |
| 121 | Progressive visual loss (HP:0000529) | 1.89381198 |
| 122 | Cardiomegaly (HP:0001640) | 1.89086436 |
| 123 | Arterial thrombosis (HP:0004420) | 1.88330539 |
| 124 | Biconcave vertebral bodies (HP:0004586) | 1.87642288 |
| 125 | Memory impairment (HP:0002354) | 1.86979601 |
| 126 | Thin bony cortex (HP:0002753) | 1.86873403 |
| 127 | Abnormality of the nasal mucosa (HP:0000433) | 1.83061458 |
| 128 | Chronic otitis media (HP:0000389) | 1.82944944 |
| 129 | Purpura (HP:0000979) | 1.81885369 |
| 130 | Autoimmune thrombocytopenia (HP:0001973) | 1.80751080 |
| 131 | Premature loss of primary teeth (HP:0006323) | 1.80499644 |
| 132 | Genu recurvatum (HP:0002816) | 1.79496377 |
| 133 | Recurrent viral infections (HP:0004429) | 1.79027062 |
| 134 | Increased IgM level (HP:0003496) | 1.78814146 |
| 135 | Abnormality of the periventricular white matter (HP:0002518) | 1.78761758 |
| 136 | T lymphocytopenia (HP:0005403) | 1.78245643 |
| 137 | Protuberant abdomen (HP:0001538) | 1.78169124 |
| 138 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.74481081 |
| 139 | Encephalitis (HP:0002383) | 1.72117445 |
| 140 | Abnormal foot bone ossification (HP:0010675) | 1.71842489 |
| 141 | Restrictive lung disease (HP:0002091) | 1.71119295 |
| 142 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.69545287 |
| 143 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.69474025 |
| 144 | Verrucae (HP:0200043) | 1.68899096 |
| 145 | Papilloma (HP:0012740) | 1.68899096 |
| 146 | Xanthomatosis (HP:0000991) | 1.66594303 |
| 147 | IgM deficiency (HP:0002850) | 1.66010177 |
| 148 | Multiple enchondromatosis (HP:0005701) | 1.65853409 |
| 149 | Abnormality of the frontal sinuses (HP:0002687) | 1.64606144 |
| 150 | Axonal loss (HP:0003447) | 1.63849324 |
| 151 | Vertebral compression fractures (HP:0002953) | 1.61595989 |
| 152 | Menorrhagia (HP:0000132) | 1.60996572 |
| 153 | Dilatation of the ascending aorta (HP:0005111) | 1.60581133 |
| 154 | Ulnar bowing (HP:0003031) | 1.60048107 |
| 155 | Mucopolysacchariduria (HP:0008155) | 1.59836228 |
| 156 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.59836228 |
| 157 | Abnormal platelet function (HP:0011869) | 1.56198178 |
| 158 | Impaired platelet aggregation (HP:0003540) | 1.56198178 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 4.70559071 |
| 2 | IRAK3 | 4.62014832 |
| 3 | EPHB1 | 4.17207751 |
| 4 | ERN1 | 3.60099229 |
| 5 | IRAK4 | 3.58361920 |
| 6 | FGR | 3.06684783 |
| 7 | DDR2 | 2.99723546 |
| 8 | MAP2K3 | 2.98403556 |
| 9 | CSK | 2.97831308 |
| 10 | BTK | 2.88432345 |
| 11 | TRPM7 | 2.87477767 |
| 12 | MAP3K14 | 2.87390261 |
| 13 | TAOK2 | 2.78884995 |
| 14 | TEC | 2.77323562 |
| 15 | RIPK4 | 2.76731558 |
| 16 | TRIB3 | 2.63507824 |
| 17 | BLK | 2.60781917 |
| 18 | STK10 | 2.59210668 |
| 19 | ERBB3 | 2.54266289 |
| 20 | MAP3K3 | 2.21022850 |
| 21 | HCK | 2.14454447 |
| 22 | PTK2 | 2.11793444 |
| 23 | FES | 2.09157447 |
| 24 | GRK6 | 2.08833658 |
| 25 | MAP3K12 | 2.01545384 |
| 26 | LRRK2 | 1.93610505 |
| 27 | KSR2 | 1.91670741 |
| 28 | CLK1 | 1.90964836 |
| 29 | ITK | 1.90021621 |
| 30 | PIM2 | 1.87773716 |
| 31 | TGFBR2 | 1.83113125 |
| 32 | MAP3K9 | 1.81349644 |
| 33 | ACVR1B | 1.80167774 |
| 34 | IKBKB | 1.79236408 |
| 35 | PTK6 | 1.79120321 |
| 36 | TESK2 | 1.70128148 |
| 37 | PRPF4B | 1.62196932 |
| 38 | PRKG2 | 1.56962826 |
| 39 | PAK4 | 1.56869279 |
| 40 | CAMKK2 | 1.56086664 |
| 41 | CDC42BPA | 1.48409634 |
| 42 | ABL2 | 1.47695268 |
| 43 | IKBKE | 1.46855428 |
| 44 | PKN2 | 1.33246931 |
| 45 | KDR | 1.31297274 |
| 46 | TTN | 1.27639403 |
| 47 | ADRBK2 | 1.26863455 |
| 48 | TYK2 | 1.26786569 |
| 49 | ALK | 1.20385144 |
| 50 | MAP3K13 | 1.20356691 |
| 51 | FRK | 1.18448548 |
| 52 | TAOK1 | 1.08116043 |
| 53 | TXK | 1.07668200 |
| 54 | RIPK1 | 1.01814655 |
| 55 | TESK1 | 1.00888987 |
| 56 | MAP3K11 | 1.00248052 |
| 57 | PTK2B | 0.95513270 |
| 58 | MAP3K5 | 0.93866484 |
| 59 | CHUK | 0.92742080 |
| 60 | ZAP70 | 0.91471040 |
| 61 | TYRO3 | 0.90922149 |
| 62 | MAP4K1 | 0.89411705 |
| 63 | TGFBR1 | 0.85326469 |
| 64 | MOS | 0.83239932 |
| 65 | ARAF | 0.76286021 |
| 66 | MARK3 | 0.74578251 |
| 67 | RPS6KA4 | 0.74366697 |
| 68 | GRK1 | 0.72634748 |
| 69 | MAPKAPK2 | 0.72414119 |
| 70 | JAK1 | 0.70780548 |
| 71 | BMPR2 | 0.69712719 |
| 72 | LIMK1 | 0.69238569 |
| 73 | IRAK2 | 0.67856615 |
| 74 | SIK3 | 0.67550494 |
| 75 | TBK1 | 0.67343257 |
| 76 | CSF1R | 0.66709569 |
| 77 | MATK | 0.65914872 |
| 78 | JAK2 | 0.65446318 |
| 79 | DAPK2 | 0.65394379 |
| 80 | MAP3K1 | 0.64115498 |
| 81 | CAMK1G | 0.62570660 |
| 82 | PRKCH | 0.62066298 |
| 83 | RAF1 | 0.62009434 |
| 84 | TNK2 | 0.60987394 |
| 85 | DMPK | 0.60808325 |
| 86 | FYN | 0.60365363 |
| 87 | EPHA3 | 0.57865510 |
| 88 | GRK7 | 0.56769509 |
| 89 | SYK | 0.56358018 |
| 90 | LYN | 0.56066794 |
| 91 | PDGFRA | 0.54721044 |
| 92 | GRK5 | 0.52834839 |
| 93 | STK11 | 0.52486031 |
| 94 | NEK9 | 0.52312434 |
| 95 | PRKCD | 0.49379095 |
| 96 | EPHB2 | 0.47281503 |
| 97 | LCK | 0.47241955 |
| 98 | MAP2K2 | 0.47022992 |
| 99 | EGFR | 0.46110848 |
| 100 | CDK6 | 0.45604566 |
| 101 | PDK1 | 0.45093759 |
| 102 | IRAK1 | 0.44254506 |
| 103 | PDPK1 | 0.44235924 |
| 104 | RPS6KA2 | 0.42580685 |
| 105 | MAP3K8 | 0.41516347 |
| 106 | MAPK4 | 0.41346914 |
| 107 | MAP2K6 | 0.41214811 |
| 108 | CAMKK1 | 0.40007655 |
| 109 | MAP3K10 | 0.38901009 |
| 110 | ICK | 0.38848392 |
| 111 | KSR1 | 0.38357162 |
| 112 | DYRK3 | 0.37842753 |
| 113 | PIK3CG | 0.36242278 |
| 114 | FGFR3 | 0.35823061 |
| 115 | ILK | 0.35463980 |
| 116 | SIK2 | 0.35209482 |
| 117 | PAK3 | 0.34285993 |
| 118 | ADRBK1 | 0.34248738 |
| 119 | FGFR1 | 0.34128945 |
| 120 | SGK3 | 0.33346049 |
| 121 | BMX | 0.32547258 |
| 122 | PRKAA2 | 0.31980285 |
| 123 | ABL1 | 0.31580870 |
| 124 | DAPK3 | 0.29875183 |
| 125 | MST4 | 0.29665018 |
| 126 | KIT | 0.28970392 |
| 127 | CAMK1D | 0.28837400 |
| 128 | MAP3K2 | 0.28413802 |
| 129 | PDGFRB | 0.26542970 |
| 130 | FGFR4 | 0.26461017 |
| 131 | ROCK2 | 0.26109063 |
| 132 | LATS2 | 0.25446128 |
| 133 | INSR | 0.24939110 |
| 134 | SIK1 | 0.24466780 |
| 135 | SRC | 0.24143063 |
| 136 | MAP2K1 | 0.23880941 |
| 137 | JAK3 | 0.23667457 |
| 138 | RPS6KA6 | 0.23491735 |
| 139 | FGFR2 | 0.22995352 |
| 140 | RPS6KA1 | 0.22862915 |
| 141 | RPS6KC1 | 0.22504771 |
| 142 | RPS6KL1 | 0.22504771 |
| 143 | MAPK7 | 0.22306406 |
| 144 | MARK2 | 0.21888175 |
| 145 | PIM1 | 0.21140610 |
| 146 | IGF1R | 0.20982400 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 4.29736486 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.67979025 |
| 3 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.65798611 |
| 4 | * Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 2.59371087 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.56756288 |
| 6 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.45341634 |
| 7 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.27037601 |
| 8 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.18315132 |
| 9 | Shigellosis_Homo sapiens_hsa05131 | 2.10298526 |
| 10 | Allograft rejection_Homo sapiens_hsa05330 | 2.04799986 |
| 11 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 2.01232664 |
| 12 | Tuberculosis_Homo sapiens_hsa05152 | 1.83833246 |
| 13 | Pertussis_Homo sapiens_hsa05133 | 1.82355146 |
| 14 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.81013018 |
| 15 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.74972847 |
| 16 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.73075138 |
| 17 | Salmonella infection_Homo sapiens_hsa05132 | 1.70968148 |
| 18 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.68265206 |
| 19 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.64459775 |
| 20 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.61011318 |
| 21 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.59854601 |
| 22 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.54654643 |
| 23 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.53943928 |
| 24 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.52822028 |
| 25 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.49935341 |
| 26 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.49014422 |
| 27 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.49011942 |
| 28 | Platelet activation_Homo sapiens_hsa04611 | 1.48514509 |
| 29 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.48173276 |
| 30 | Histidine metabolism_Homo sapiens_hsa00340 | 1.46461142 |
| 31 | Mineral absorption_Homo sapiens_hsa04978 | 1.43929412 |
| 32 | Legionellosis_Homo sapiens_hsa05134 | 1.41528591 |
| 33 | Prion diseases_Homo sapiens_hsa05020 | 1.36626998 |
| 34 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.35349972 |
| 35 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.35103959 |
| 36 | Amoebiasis_Homo sapiens_hsa05146 | 1.33183687 |
| 37 | Malaria_Homo sapiens_hsa05144 | 1.32773060 |
| 38 | Phagosome_Homo sapiens_hsa04145 | 1.31064708 |
| 39 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.29696122 |
| 40 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.21984381 |
| 41 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.15330245 |
| 42 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.13156041 |
| 43 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.11029460 |
| 44 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.10729020 |
| 45 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.09533480 |
| 46 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.09423449 |
| 47 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.08348621 |
| 48 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.07009580 |
| 49 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.06443285 |
| 50 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.04045635 |
| 51 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.03097101 |
| 52 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.02962899 |
| 53 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.02773279 |
| 54 | Insulin resistance_Homo sapiens_hsa04931 | 1.02501673 |
| 55 | Asthma_Homo sapiens_hsa05310 | 1.01600853 |
| 56 | Viral myocarditis_Homo sapiens_hsa05416 | 1.01591775 |
| 57 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.00610832 |
| 58 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.98282801 |
| 59 | * TNF signaling pathway_Homo sapiens_hsa04668 | 0.97141977 |
| 60 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.93738017 |
| 61 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.90920555 |
| 62 | Focal adhesion_Homo sapiens_hsa04510 | 0.89115583 |
| 63 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.88516856 |
| 64 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.87330332 |
| 65 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.86096829 |
| 66 | Endocytosis_Homo sapiens_hsa04144 | 0.85613798 |
| 67 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.84070699 |
| 68 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.82939529 |
| 69 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.80208155 |
| 70 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.79757643 |
| 71 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.75379741 |
| 72 | Adherens junction_Homo sapiens_hsa04520 | 0.75086886 |
| 73 | Galactose metabolism_Homo sapiens_hsa00052 | 0.75033177 |
| 74 | * Hepatitis B_Homo sapiens_hsa05161 | 0.74761802 |
| 75 | Influenza A_Homo sapiens_hsa05164 | 0.74070043 |
| 76 | Glioma_Homo sapiens_hsa05214 | 0.72944958 |
| 77 | * Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.72324726 |
| 78 | * Bladder cancer_Homo sapiens_hsa05219 | 0.70707854 |
| 79 | Measles_Homo sapiens_hsa05162 | 0.68807035 |
| 80 | Lysosome_Homo sapiens_hsa04142 | 0.66665085 |
| 81 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.66398641 |
| 82 | Hepatitis C_Homo sapiens_hsa05160 | 0.66241057 |
| 83 | Apoptosis_Homo sapiens_hsa04210 | 0.65717742 |
| 84 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.64655282 |
| 85 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.62750959 |
| 86 | Retinol metabolism_Homo sapiens_hsa00830 | 0.62241500 |
| 87 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.62137124 |
| 88 | Colorectal cancer_Homo sapiens_hsa05210 | 0.61888339 |
| 89 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.61731840 |
| 90 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.60050752 |
| 91 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.59585722 |
| 92 | Other glycan degradation_Homo sapiens_hsa00511 | 0.58188431 |
| 93 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.58104083 |
| 94 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.57361180 |
| 95 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.56909639 |
| 96 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.56652728 |
| 97 | Endometrial cancer_Homo sapiens_hsa05213 | 0.55782610 |
| 98 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.54185760 |
| 99 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.54013632 |
| 100 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.53924991 |
| 101 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.53626681 |
| 102 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.49157236 |
| 103 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.48251416 |
| 104 | * Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.47893130 |
| 105 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.47442309 |
| 106 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.45597494 |
| 107 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.44351352 |
| 108 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.41107630 |
| 109 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.40688349 |
| 110 | * Pathways in cancer_Homo sapiens_hsa05200 | 0.40085902 |
| 111 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.39316356 |
| 112 | Long-term depression_Homo sapiens_hsa04730 | 0.39028386 |
| 113 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.38862798 |
| 114 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.38737405 |
| 115 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.36606479 |
| 116 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.36183990 |
| 117 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.34977631 |
| 118 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.34596246 |
| 119 | * Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.34240583 |
| 120 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.32747376 |
| 121 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.32552681 |
| 122 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.32053978 |
| 123 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.31667311 |
| 124 | Renin secretion_Homo sapiens_hsa04924 | 0.29706800 |
| 125 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.25887456 |
| 126 | HTLV-I infection_Homo sapiens_hsa05166 | 0.24835671 |
| 127 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.24529585 |
| 128 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.19727809 |
| 129 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.18597974 |
| 130 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.17318037 |
| 131 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.15696752 |

